Department of Epidemiology & Biostatistics, Joe C. Wen School of Population & Public Health, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, CA, USA
Auto-generated profile, based on publicly available information
Jiahui Dai
Department of Epidemiology & Biostatistics, Joe C. Wen School of Population & Public Health, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, CA, USA
Background: When studying drug effects using observational data, time-related biases may exist and result in spurious associations. Numerous observational studies have investigated metformin and dementia risk, but have reported inconsistent findings, some of which might be caused by unaddressed time-related biases. Immortal time bias biases the results toward a “protective” effect, whereas time-lag and time-window biases can lead to either a “detrimental” or “protective” effect. Objective: To conduct a systematic review examining time-related biases in the literature on metformin and dementia. Methods: The electronic databases PubMed, Web of Science, and ProQuest were searched for the terms “Metformin” AND (“dementia” OR “Alzheimer’s Disease” OR “cognitive impairment"). These databases were searched from inception through 09/24/2021. Only English language articles and human research were eligible. Results: Seventeen studies were identified: thirteen cohort studies, two case-control studies, and two nested case-control studies. Eleven (64.7%) studies reported a reduced risk of dementia associated with metformin use; two (11.8%) suggested metformin increased dementia risk, while four (23.5%) concluded no significant associations. Eight (61.5%) of thirteen cohort studies had immortal time bias or did not clearly address it. Fifteen (88.2%) of seventeen reviewed studies had time-lag bias or did not clearly address it. Two (50.0%) of four case-control studies did not explicitly address time-window bias. The studies that addressed most biases concluded no associations between metformin and dementia risk. Conclusion: None of the reviewed studies clearly addressed relevant time-related biases, illustrating time-related biases are common in observational studies investigating the impact of anti-diabetic medications on dementia risk.
Jiahui Dai, Xiaoyi Niu, Ann Bullock, Spero M. Manson, Joan O’Connell, Luohua Jiang; Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among American Indian and
13 February 2025 in The Lancet Regional Health - Americas
Dementia is an increasing concern among American Indian and Alaska Native (AI/AN) communities, yet machine learning models utilizing electronic health record (EHR) data have not been developed or validated for this population. This study aimed to develop a two-year dementia risk prediction model for AI/AN individuals actively using Indian Health Service (IHS) and Tribal health services. Seven years of data were obtained from the IHS National Data Warehouse and related EHR databases and divided into a five-year baseline period (FY2007–2011) and a two-year dementia prediction period (FY2012–2013). Four algorithms were assessed: logistic regression, Least Absolute Shrinkage and Selection Operator (LASSO), random forest, and eXtreme Gradient Boosting (XGBoost). Dementia Risk Score (DRS)-based and extended models were developed for each algorithm, with performance evaluated by the area under the receiver operating characteristic curve (AUC). The study cohort included 17,398 AI/AN adults aged ≥ 65 years who were dementia-free at baseline, of whom 59.8% were female. Over the two-year follow-up, 611 individuals (3.5%) were diagnosed with incident dementia. Extended models for logistic regression, LASSO, and XGBoost performed comparably: AUCs (95% CI) of 0.83 (0.79, 0.86), 0.83 (0.79, 0.86), and 0.82 (0.79, 0.86). These top-performing models shared 12 of the 15 highest-ranked predictors, with novel predictors including service utilization. Machine learning algorithms utilizing EHR data can effectively predict two-year dementia risk among AI/AN older adults. These models could aid IHS and Tribal health clinicians in identifying high-risk individuals, facilitating timely interventions and improved care coordination. 10.13039/100000002 NIH .
21 October 2024 in Diabetes, Obesity and Metabolism
Objectives: We examined associations of social engagement and interpersonal connectedness with cognitive function, distress, and mental and physical health in middle-aged and older American Indian and Alaska Native (AI/AN) adults. Methods: Data from 552 AI/ANs aged 55+ in the Rocky Mountain region (2019–2023). Social engagement and interpersonal connectedness were assessed using validated scales. Outcomes included cognitive impairment (adapted AD8), distress (K6 scale), and self-reported mental and physical health. Poisson regression models examined associations. Results: Greater social engagement was significantly associated with a lower risk of cognitive impairment, lower odds of suboptimal mental, and physical health among AI/AN females, while greater interpersonal connectedness was significantly associated with lower risk of cognitive impairment and reduced odds of the other outcomes among AI/AN males. Associations were stronger in urban than rural areas. Discussion: Culturally tailored interventions that promote social connectedness may enhance well-being in this underserved population. Further research on sex and residence differences is warranted.